Stock ESPR ESPERION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Esperion Therapeutics, Inc.

Equities

ESPR

US29664W1053

Real-time Estimate Cboe BZX
Other stock markets
 01:22:33 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.505 USD +7.51% Intraday chart for Esperion Therapeutics, Inc. +10.01% -15.75%
May. 22 Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. Jointly Announce That European Commission Has Approved the Label Update of Both NILEMDO® (bempedoic acid) and NUSTENDI® (bempedoic acid / ezetimibe fixed-dose combination), as Treatments for Hypercholesterolemia and to Reduce the Risk of Adverse Cardiovascular Events CI
May. 20 Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Today on Wall Street: How will inflation impact economic recovery?Today on Wall Street: How will inflation impact economic recovery? May 06, 2021 at 09:37 am EDT
Today's analyst recommendations: Lowe, National Grid, Pearson, Thomson Reuters, CVS...TODAY'S ANALYST RECOMMENDATIONS : Lowe, National Grid, Pearson, Thomson Reuters, CVS... May 06, 2021 at 06:22 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ESPR Stock
  4. News Esperion Therapeutics, Inc.
  5. MarketScreener Editorial Features